Improved renal function after kidney transplantation is associated with heme oxygenase-1 polymorphism

Clinical Transplantation

Volumn 22, Issue 5, 2008, Pages 609-616

  Ozaki, K S ^a   Marques, G M ^a   Nogueira, E ^a   Feitoza, R Q ^a   Cenedeze, M A ^a   Franco, M F ^a   Mazzali, M ^b   Soares, M P ^c   Pacheco Silva, A ^a   Câmara, Niels Olsen Saraiva ^a,d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Graft survival; Heme oxygenase 1; Polymorphism; Renal graft function; Renal transplantation

Indexed keywords

DNA; GUANOSINE; HEME OXYGENASE 1; THYMIDINE;

ADULT; ALLELE; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DELAYED GRAFT FUNCTION; DNA EXTRACTION; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN CELL; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TREATMENT OUTCOME;

ADULT; CASE-CONTROL STUDIES; DINUCLEOTIDE REPEATS; FEMALE; GENE FREQUENCY; GRAFT SURVIVAL; HEME OXYGENASE-1; HUMANS; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS, GENETIC; TISSUE DONORS; YOUNG ADULT;

EID: 52649084215     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00832.x     Document Type: Article

References (47)

1. Wolf RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999: 341: 1725.
2. Cecka JM. The UNOS Scientific Renal Transplant Registry - ten years of kidney transplants. Clin Transplant 1997: 1.
3. Hariharan S, Mc Bride MA, Cherikh WS et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002: 62: 311.
4. Fitzsimmons W, Thompson D, Hariharan S, Van Veldhuisen P. Serum creatinine as a surrogate endpoint for graft loss in kidney transplantation: Validation efforts from multicentre trials. Am J Transplant 2002. 2: 272 (Abstract 533).
5. First MR. Renal function as a predictor of long-term graft survival in renal transplant patients. Nephrol Dial Transplant 2003: 18 (Suppl. 1): i3.
6. Bach FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: A regulatory response to injury. Immunol Today 1997: 18: 483.
7. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003: 24: 449.
8. Ferran C. Protective genes in the vessel wall: Modulators of graft survival and function. Transplantation 2006: 82 (Suppl. 1): S36.
9. Lemos FB, Ijzermans JN, Zondervan PE et al. Differential expression of heme oxygenase-1 and vascular endothelial growth factor in cadaveric and living donor kidneys after ischemia-reperfusion. J Am Soc Nephrol 2003: 14: 3278.
10. Opipari AW Jr., Hu HM, Yabkowitz R, Dixit VM. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 1992: 267: 12424.
11. Cooper JT, Stroka DM, Brastjan C, Palmetshofer A, Bach FH, Ferran C. A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J Biol Chem 1996: 271: 18068.
12. Badrichani AZ, Stroka DM, Bilbao G, Curiel DT, Bach FH, Ferran C. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J Clin Invest 1999: 103: 543.
13. Pilmore HL, Eris JM, Painter DM, Bishop GA, Mc Caughan GW. Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation 1999: 67: 929.
14. Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 1998: 152: 711.
15. Fredenburgh LE, Perrella MA, Mitsialis SA. The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol 2007: 36: 158.
16. Morgan L, Hawe E, Palmen J, Montgomery H, Humphries SE, Kitchen N. Polymorphism of the heme oxygenase-1 gene and cerebral aneurysms. Br J Neurosurg 2005: 19: 317.
17. Maines MD. Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1988: 2: 2557.
18. Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 1969: 244: 6388.
19. Agarwal A, Kim Y, Matas AJ, Alam J, Nath KA. Gas-generating systems in acute renal allograft rejection in the rat. Co-induction of heme oxygenase and nitric oxide synthase. Transplantation 1996: 61: 93.
20. Bach FH, Ferran C, Hechenleitner P et al. Accommodation of vascularized xenografts: Expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997: 3: 196.
21. Soares MP, Lin Y, Anrather J et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998: 4: 1073.
22. Ke B, Coito AJ, Kato H et al. Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients. J Immunol 2000: 164: 5739.
23. Yamada N, Yamaya M, Okinaga S et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000: 66: 187.
24. Kimpara T, Takeda A, Watanabe K et al. Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet 1997: 100: 145.
25. Ono K, Mannami T, Iwai N. Association of a promoter variant of the haeme oxygenase-1 gene with hypertension in women. J Hypertens 2003: 21: 1497.
26. Ono K, Goto Y, Takagi S et al. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis 2004: 173: 315.
27. Brydun A, Watari Y, Yamamoto Y et al. Reduced expression of heme oxygenase-1 in patients with coronary atherosclerosis. Hypertens Res 2007: 30: 341.
28. Baan C, Peeters A, Lemos F et al. Fundamental role for HO-1 in the self-protection of renal allografts. Am J Transplant 2004: 4: 811.
29. Chen YH, Chau LY, Lin MW et al. Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur Heart J 2004: 25: 39.
30. Schillinger M, Exner M, Minar E et al. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: A novel vascular protective factor. J Am Coll Cardiol 2004: 43: 950.
31. Exner M, Böhmig GA, Schillinger M. Donor heme oxygenase-1 genotype is associated with renal allograft function. Transplantation 2004: 77: 538.
32. Nankivell BJ,B orrows RJ,F ung CL,O 'Connell PJ,A llen RD, Chapman RJ. The natural history of chronic allograft nephropathy. N Engl J Med 2003: 349: 2326.
33. Gallagher MP, Hall B, Craig J et al. A randomized controlled trial of cyclosporine withdrawal in renal-transplant recipients: 15-year results. Transplantation 2004: 78: 1653.
34. Dudley C, Pohanka E, Riad H et al. Mycophenolate mofetil substitution for cyclosporine A in renal transplant recipients with chronic progressive allograft dysfunction: The "creeping creatinine" study. Transplantation 2005: 79: 466.
35. Soares MP, Brouard S, Smith RN, Bach FH. Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs. Immunol Rev 2001: 184: 275.
36. Sato K, Balla J, Otterbein L et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001: 166: 4185.
37. Brouard S, Berberat PO, Tobiasch E et al. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem 2002: 277: 17950.
38. Blydt-Hansen TD, Katori M, Lassman C et al. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J Am Soc Nephrol 2003: 14: 745.
39. Salahudeen AA, Jenkins JK, Huang H, Ndebele K, Salahudeen AK. Overexpression of heme oxygenase protects renal tubular cells against cold storage injury: Studies using hemin induction and HO-1 gene transfer. Transplantation 2001: 72: 1498.
40. Hirai H, Kubo Y, Yamaya M et al. Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood 2003: 102: 1619.
41. Courtney AE, Mc Namee PT, Heggarty S, Middleton D, Maxwell AP. Association of functional heme oxygenase-1 gene promoter polymorphism with renal transplantation outcomes. Am J Transplant 2007: 7: 908.
42. Exner M, Minar E, Wagner O, Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 2004: 37: 1097.
43. Katori M, Buelow R, Ke B et al. Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway. Transplantation 2002: 73: 287.
44. Goncalves GM, Cenedeze MA, Feitoza CQ et al. The role of heme oxygenase 1 in rapamycin-induced renal dysfunction after ischemia and reperfusion injury. Kidney Int 2006: 70: 1742.
45. Martins PN, Reuzel-Selke A, Jurisch A et al. Induction of heme oxygenase-1 in the donor reduces graft immunogenicity. Transplant Proc 2005: 37: 384.
46. Tullius SG, Nieminen-KelhäM, Buelow R et al. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 2002: 74: 591.
47. Goncalves GM, Cenedeze MA, Feiroza CQ et al. Heme oxygenase 1 and renal ischemia and reperfusion injury: The impact of immunosuppressive drug. Int Immunopharmacol 2006: 6: 1966.